Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atiprimod in advanced cancer
NCT00214838Phase 2Unknown
- Sponsor
- Callisto Pharmaceuticals, Inc.
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atiprimod in cancer, sponsored by Callisto Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
atiprimod
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00214838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00214838.